CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 155 filers reported holding CHINOOK THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $31,740,875 | +60.8% | 826,155 | -10.8% | 0.23% | +67.2% |
| Q1 2023 | $19,734,445 | -18.7% | 926,155 | 0.0% | 0.14% | -16.5% |
| Q4 2022 | $24,264,124 | +41.7% | 926,155 | +6.3% | 0.16% | +35.5% |
| Q3 2022 | $17,128,000 | +12.4% | 871,155 | 0.0% | 0.12% | -3.2% |
| Q2 2022 | $15,236,000 | -21.4% | 871,155 | -26.5% | 0.12% | -5.3% |
| Q1 2022 | $19,391,000 | +7.6% | 1,185,314 | +7.3% | 0.13% | +14.8% |
| Q4 2021 | $18,021,000 | +56.5% | 1,104,902 | +22.4% | 0.12% | +47.4% |
| Q3 2021 | $11,516,000 | -6.8% | 902,537 | +3.1% | 0.08% | -8.2% |
| Q2 2021 | $12,357,000 | – | 875,124 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 14,158 | $12,782,000 | 5.70% |
| Samsara BioCapital, LLC | 3,168,388 | $44,738,000 | 5.52% |
| FRAZIER MANAGEMENT LLC | 1,100,000 | $15,532,000 | 1.43% |
| Altium Capital Management LP | 416,567 | $5,882,000 | 1.36% |
| Affinity Asset Advisors, LLC | 200,000 | $2,824,000 | 1.01% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 170,821 | $2,412,000 | 0.64% |
| Vivo Capital, LLC | 872,151 | $12,315,000 | 0.53% |
| EcoR1 Capital, LLC | 931,650 | $13,155,000 | 0.49% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $17,452,000 | 0.31% |
| Rubric Capital Management LP | 325,863 | $4,601,000 | 0.29% |